Publications by authors named "Francisco Javier Lavid"
Background: We aimed to describe a 2-year outcome of eyes managed by practitioners benchmarked using a funnel plot by their frequency of treatment using vascular endothelial growth factor (VEGF) inhibitors for naive retinal vein occlusion (RVO).
Methods: A multicentre, international, observational study of 29 doctors in 12 countries managing 1110 eyes with RVO commencing VEGF inhibitors between 1 January 2012-2022 tracked in the Fight Retinal Blindness! registry.
Results: We identified 3 outlying 'intensive' practitioners (managing 350/1110 eyes [32%]), 22 'typical' practitioners (604/1110, [54%]) and 4 outlying 'relaxed' practitioners (156/1110, [14%]) with respective 24-month outcomes in Branch and Central RVO including the primary outcome, mean adjusted change in visual acuity (VA) in BRVO: +16.
Article Synopsis
- The study evaluates the clinical outcomes of cataract surgery in patients with cystoid macular edema (CMO) due to retinal vein occlusions (RVOs), comparing those who had surgery to matched individuals who did not.
- Results showed a significant improvement in visual acuity (VA) for patients who underwent cataract extraction (+9.9 letters), while the control group experienced a decline (-2.4 letters) after 12 months.
- Post-surgery, the eyes that had cataract surgery required more injections for treatment on average (5 injections) compared to the controls (4 injections), highlighting a possible increased need for ongoing care after surgery.
Purpose: To compare 1-year outcomes of eyes with diabetic macular edema (DME) treated in routine clinical practice based on the proportion of visits where intravitreal VEGF inhibitor injections were delivered.
Design: Cohort study.
Participants: There were 2288 treatment-naive eyes with DME starting intravitreal VEGF inhibitor therapy from October 31, 2015 to October 31, 2021 from the Fight Retinal Blindness! international outcomes registry.
Purpose: This paper aimed to present daily-practice recommendations for the management of diabetic macular edema (DME) patients based on available scientific evidence and the clinical experience of the consensus panel.
Methods: A group of Spanish retina experts agreed to discuss different aspects related with the clinical management of DME patients.
Results: Panel was mainly focused on therapeutic objectives in DME management; definition terms; and role of biomarkers as prognostic and predictive factors to intravitreal treatment response.